Detalhe da pesquisa
1.
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.
Br J Cancer
; 127(5): 908-915, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35650277
2.
CKLF and IL1B transcript levels at diagnosis are predictive of relapse in children with pre-B-cell acute lymphoblastic leukaemia.
Br J Haematol
; 193(1): 171-175, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33620089
3.
Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab.
Pediatr Blood Cancer
; 68(5): e28922, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33638292
4.
A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.
Br J Haematol
; 180(4): 550-562, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29194562
5.
Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia.
Blood
; 128(7): 911-22, 2016 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27229005
6.
Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia.
Br J Haematol
; 168(3): 395-404, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25312094
7.
High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment.
Haematologica
; 102(12): e490-e493, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935844
8.
Correlation between a 10-color flow cytometric measurable residual disease (MRD) analysis and molecular MRD in adult B-acute lymphoblastic leukemia.
Cytometry B Clin Cytom
; 102(2): 115-122, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34806309
9.
Sensitive Measurement of Minimal Residual Disease in Blood by HAT-PCR.
J Mol Diagn
; 24(6): 632-641, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35430373
10.
Enrichment of atypical hyperdiploidy and IKZF1 deletions detected by SNP-microarray in high-risk Australian AIEOP-BFM B-cell acute lymphoblastic leukaemia cohort.
Cancer Genet
; 242: 8-14, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32058318
11.
Primary leukocyte screens for innate immune agonists.
J Biomol Screen
; 14(6): 723-30, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19525489
12.
Improving the identification of high risk precursor B acute lymphoblastic leukemia patients with earlier quantification of minimal residual disease.
PLoS One
; 8(10): e76455, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24146872